Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer

被引：3
|
作者：
Piccioli A. [1 ]
机构：
[1] Orthopaedic Oncologic Unit, ‘‘Palazzo Baleani’’ Cancer Centre, Policlinico Umberto I, Rome
来源：
European Journal of Orthopaedic Surgery & Traumatology | 2015年 / 25卷 / 1期
关键词：
Bisphosphonate; Breast cancer; Jaw osteonecrosis;
D O I：
10.1007/s00590-013-1293-z
中图分类号：
学科分类号：
摘要：
Bisphosphonate represents a well-established treatment option in the management of metastatic bone disease and bone loss/osteoporosis in women with breast cancer. These drugs reduce osteoclast. Some bisphosphonate also have osteoblastic function leading to a reducted bone turnover and thereby skeletal-related events. The aim of this review is to evaluate the bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer. Based on the proven effect of bone protection during adjuvant endocrine therapy, new treatment guidelines recommend the routine use of bisphosphonates to prevent bone loss during adjuvant therapy, which may likely become the standard practice.. © Springer-Verlag France 2013.
引用
收藏
页码：29 / 37
页数：8
相关论文
共 50 条
  • [31] A cutaneous presentation of bisphosphonate-related osteonecrosis of the jaw
    McCusker, S.
    May, C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 932 - 934
  • [32] Bisphosphonate-Related Osteonecrosis of the Jaw: Tip of the Iceberg
    Knight, Robert John W.
    Reddy, Chaithan
    Rtshiladze, Michael A.
    Lvoff, Gregory
    Sherring, David
    Marucci, Damian
    JOURNAL OF CRANIOFACIAL SURGERY, 2010, 21 (01) : 25 - 32
  • [33] Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
    Sigua-Rodriguez, Eder Alberto
    Ribeiro, Renato da Costa
    Ramos de Brito, Ana Caroline
    Alvarez-Pinzon, Natalia
    de Albergaria-Barbosa, Jose Ricardo
    INTERNATIONAL JOURNAL OF DENTISTRY, 2014, 2014
  • [34] The Predicting Factors of Bisphosphonate-related Osteonecrosis of the Jaw
    Universidade Fernando Pessoa
    1600,
  • [35] Bisphosphonate-related osteonecrosis of the jaw: Clinical series (45 patients)
    Salino, S.
    Bodard, A. G.
    Gourmet, R.
    ORAL ONCOLOGY, 2009, : 137 - 138
  • [36] Treatment for bisphosphonate-related osteonecrosis of the jawQuestion: What is the best treatment for bisphosphonate-related osteonecrosis of the jaw (BRONJ)?
    Silvia Spivakovsky
    Evidence-Based Dentistry, 2017, 18 (2) : 56 - 56
  • [37] Bisphosphonate-Related Osteonecrosis of the Jaw: Role of MRI
    Filonzi, G.
    Bazzocchi, A.
    Spinnato, P.
    Ciccarese, F.
    Baglivo, E.
    Salizzoni, E.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
  • [38] Bisphosphonate-related osteonecrosis of the jaw: the Florence experience
    Borgioli, Alberto
    Duvina, Marco
    Brancato, Leila
    Viviani, Christian
    Brandi, Maria Luisa
    Tonelli, Paolo
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2007, 4 (01) : 48 - 52
  • [39] Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw
    Thumbigere-Math, V.
    Michalowicz, B. S.
    de Jong, E. P.
    Griffin, T. J.
    Basi, D. L.
    Hughes, P. J.
    Tsai, M. L.
    Swenson, K. K.
    Rockwell, L.
    Gopalakrishnan, R.
    ORAL DISEASES, 2015, 21 (01) : 46 - 56
  • [40] Bisphosphonate-Related Osteonecrosis of the Jaw and Left Thumb
    Longo, Raffaele
    Castellana, Maria Angela
    Gasparini, Giampietro
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : E242 - E243
12345